AEMD Share Price Performance
US$1.20
-1.12 (-48.28%)
Price US$1.20
Share PriceUS$1.20
AEMD Community Narratives
There are no narratives available yet.
Recent AEMD News & Updates
No updates
Aethlon Medical, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 13, 2025
- Earnings per share (EPS)
- -6.66
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 3.5%
Aethlon Medical, Inc. Competitors
About AEMD
- Founded
- 1984
- Employees
- 9
- CEO
- WebsiteView website
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening viral infectious, diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
U.S. Market Performance
- 7 Days: -1.2%
- 3 Months: 13.1%
- 1 Year: 22.8%
- Year to Date: 7.3%
Over the last 7 days, the market has dropped 1.2%, driven by a pullback of 4.7% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 23% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading